Teti A - Search Results

1

Evaluation of metastatic potential in prostate carcinoma: an in vivo model.

Angelucci A, Gravina GL, Rucci N, Festuccia C, Muzi P, Vicentini C, Teti A, Bologna M. Angelucci A, et al. Among authors: teti a. Int J Oncol. 2004 Dec;25(6):1713-20. Int J Oncol. 2004. PMID: 15547709

2

Osteoblast-conditioned media stimulate membrane vesicle shedding in prostate cancer cells.

Millimaggi D, Festuccia C, Angelucci A, D'Ascenzo S, Rucci N, Flati S, Bologna M, Teti A, Pavan A, Dolo V. Millimaggi D, et al. Among authors: teti a. Int J Oncol. 2006 Apr;28(4):909-14. Int J Oncol. 2006. PMID: 16525640

3

Suppression of EGF-R signaling reduces the incidence of prostate cancer metastasis in nude mice.

Angelucci A, Gravina GL, Rucci N, Millimaggi D, Festuccia C, Muzi P, Teti A, Vicentini C, Bologna M. Angelucci A, et al. Among authors: teti a. Endocr Relat Cancer. 2006 Mar;13(1):197-210. doi: 10.1677/erc.1.01100. Endocr Relat Cancer. 2006. PMID: 16601288

4

Osteopontin modulates prostate carcinoma invasive capacity through RGD-dependent upregulation of plasminogen activators.

Angelucci A, Festuccia C, D'Andrea G, Teti A, Bologna M. Angelucci A, et al. Among authors: teti a. Biol Chem. 2002 Jan;383(1):229-34. doi: 10.1515/BC.2002.024. Biol Chem. 2002. PMID: 11928818

5

Human prostatic tumor cells in culture produce growth and differentiation factors active on osteoblasts: a new biological and clinical parameter for prostatic carcinoma.

Festuccia C, Teti A, Bianco P, Guerra F, Vicentini C, Tennina R, Villanova I, Sciortino G, Bologna M. Festuccia C, et al. Among authors: teti a. Oncol Res. 1997;9(8):419-31. Oncol Res. 1997. PMID: 9436195

6

Osteoblast-derived TGF-beta1 modulates matrix degrading protease expression and activity in prostate cancer cells.

Festuccia C, Angelucci A, Gravina GL, Villanova I, Teti A, Albini A, Bologna M. Festuccia C, et al. Among authors: teti a. Int J Cancer. 2000 Feb 1;85(3):407-15. Int J Cancer. 2000. PMID: 10652434

7

In vivo bone metastases, osteoclastogenic ability, and phenotypic characterization of human breast cancer cells.

Rucci N, Ricevuto E, Ficorella C, Longo M, Perez M, Di Giacinto C, Funari A, Teti A, Migliaccio S. Rucci N, et al. Among authors: teti a. Bone. 2004 Apr;34(4):697-709. doi: 10.1016/j.bone.2003.07.012. Bone. 2004. PMID: 15050901

8

Inhibition of protein kinase c-Src reduces the incidence of breast cancer metastases and increases survival in mice: implications for therapy.

Rucci N, Recchia I, Angelucci A, Alamanou M, Del Fattore A, Fortunati D, Susa M, Fabbro D, Bologna M, Teti A. Rucci N, et al. Among authors: teti a. J Pharmacol Exp Ther. 2006 Jul;318(1):161-72. doi: 10.1124/jpet.106.102004. Epub 2006 Apr 20. J Pharmacol Exp Ther. 2006. PMID: 16627750

9

Osteomimicry: how tumor cells try to deceive the bone.

Rucci N, Teti A. Rucci N, et al. Among authors: teti a. Front Biosci (Schol Ed). 2010 Jun 1;2(3):907-15. doi: 10.2741/s110. Front Biosci (Schol Ed). 2010. PMID: 20515833 Free article. Review.

10

Receptor activator of NF-kappaB ligand enhances breast cancer-induced osteolytic lesions through upregulation of extracellular matrix metalloproteinase inducer/CD147.

Rucci N, Millimaggi D, Mari M, Del Fattore A, Bologna M, Teti A, Angelucci A, Dolo V. Rucci N, et al. Among authors: teti a. Cancer Res. 2010 Aug 1;70(15):6150-60. doi: 10.1158/0008-5472.CAN-09-2758. Epub 2010 Jul 14. Cancer Res. 2010. PMID: 20631064

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

266 results

Search Page

Filters